Analyst Ratings For NASDAQ:GNMK – GenMark Diagnostics (NASDAQ:GNMK)
Today, Needham & Company LLC reiterated its Buy rating on NASDAQ:GNMK – GenMark Diagnostics (NASDAQ:GNMK) with a price target of $11.00.
Some recent analyst ratings include
- 4/24/2018-Needham & Company LLC Reiterated Rating of Buy.
- 11/3/2017-Cowen Reiterated Rating of Buy.
- 11/3/2017-Raymond James Reiterated Rating of Outperform .
- 9/18/2017-Bank of America initiated coverage with a Buy rating.
- On 4/12/2018 Eric Stier, SVP, sold 10,000 with an average share price of $5.46 per share and the total transaction amounting to $54,600.00.
- On 3/2/2018 Eric Stier, SVP, sold 341 with an average share price of $4.00 per share and the total transaction amounting to $1,364.00.
- On 3/1/2018 Michael Kagnoff, Director, bought 10,000 with an average share price of $4.22 per share and the total transaction amounting to $42,200.00.
- On 2/26/2018 Hany Massarany, Insider, sold 17,300 with an average share price of $4.17 per share and the total transaction amounting to $72,141.00.
- On 2/26/2018 Jennifer Anne Williams, SVP, sold 4,911 with an average share price of $4.17 per share and the total transaction amounting to $20,478.87.
- On 2/26/2018 Scott Mendel, CFO, sold 6,275 with an average share price of $4.17 per share and the total transaction amounting to $26,166.75.
- On 2/21/2018 Jennifer Anne Williams, SVP, sold 5,147 with an average share price of $4.40 per share and the total transaction amounting to $22,646.80.
Recent Trading Activity for NASDAQ:GNMK – GenMark Diagnostics (NASDAQ:GNMK)
Shares of NASDAQ:GNMK – GenMark Diagnostics closed the previous trading session at 6.11 down -0.08 1.29% with 16135 shares trading hands.